Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01215136
Title First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoosier Cancer Research Network
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.